1.Effects of Modified Jianpi Yishen Decoction on Urinary Osteopontin of Calcium Oxalate Nephrolithiasis Patients After Operation
Yan WANG ; Feng LIN ; Xueyun WENG ; Xumin XU ; Shaolong YU ; Zhifeng CHEN ; Zhipeng WEN
Chinese Journal of Information on Traditional Chinese Medicine 2015;(7):36-39
Objective To observe the effects of modified Jianpi Yishen Decoction on urinary osteopontin (OPN) in calcium oxalate nephrolithiasis patients after percutaneous nephrolithotomy (PCNL) or ureteroscope lithotomy (URL);To clarify the mechanism of modified Jianpi Yishen Decoction on the prevention of calcium oxalate kidney stones. Methods Totally 116 calcium oxalate nephrolithiasis patients were randomly divided into trial group (62 cases) and control group (54 cases). The trial group took modified Jianpi Yishen Decoction every other day, while the control group took potassium sodium hydrogen citrate granules three times a day. The concentrations of OPN, urinary calcium and urinary oxalic acid of the patients in the two groups were observed before treatment and 2 weeks and 4 weeks of treatment. Results The concentration of urinary OPN of 2 weeks and 4 weeks of the treatment in the trial group was significantly increased compared with before treatment (P<0.05), and the difference was statistically significant compared with the control group (P<0.05). The concentration of urinary OPN in the control group had no significant change after treatment (P>0.05). The differences in the concentrations of urinary calcium and urinary oxalic acid of the two groups between before and after treatment were not significant (P>0.05). Conclusion Modified Jianpi Yishen Decoction can effectively restrain the formation of the calcium oxalate stones by increasing the level of urinary OPN, which demonstrates effective prevention in the calcium oxalate nephrolithiasis patients after PCNL or URL.
2.Genomic and phylogenetic analysis of porcine mitochondrial genomes of Rongshui miniature pig
Jiayue XU ; Hehe SHI ; Xumin WANG ; Xiang GAO ; Xiyong YU ; Jun YU ; Xiaojiang TANG
Chinese Journal of Comparative Medicine 2015;(3):28-34
Objective Assembly whole mitochondrial genome sequence of Rongshui miniature pig ( RMP ) breed and analysis the structure of mitochondrion based on the next-generation sequecing method.Comparison of phylogenetic relationship and genetic diversity among different pig breeds.Methods We collected peripheral venous blood sample from RMP and constructed two paired-end sequencing libraries.A whole-genome shotgun sequencing strategy and Illumina Genome Analyser sequencing technology were used in our study.Results The mitochondrial genome of RMP consists of 13 protein coding genes, 2 ribosomal RNA genes, 22 transfer RNA genes and the length of pig is 16888 bp.The GC content of this pig mitochondrial genome is about 44 %.Based on phlogenetic analysis, population genetic analysis, our findings confirmed that the ancestral cluster in East Asia mainly occurred among Diannan 7#pig, Hainan wild boar, Lanyu and RMP.Conclusion RMP, a typical miniature pig breed in China, is an earlier ancestor than Lanyu pig breed.
4.Surveillance of Creutzfeldt-Jakob diseases cases in Guizhou Province,China, 2010-2015
Weijia JIANG ; Ling JIAO ; He HUANG ; Shijun LI ; Yan LIU ; Yinwu ZHU ; Zhu XU ; Meilu SUN ; Xumin FANG ; Lu HAN ; Jie XIONG ; Lijun CAI
Chinese Journal of Zoonoses 2017;33(5):436-440
We analyze the epidemiology,clinical features,and outcome of the patients with Creutzfeldt-Jakob diseases (CJD) in Guizhou Province from 2010 to 2015.The epidemiology,clinical characteristics and follow-up data of CJD suspected patients obtained from Guizhou CJD surveillance network were analyzed.The testing results of cerebrospinal fluid (CFS) and blood from the patients were also collected and analyzed.Results showed that a total of 11 CJD cases was found from 23 reported CJD suspected patients in Guizhou from 2010 to 2015,including 8 probable sporadic CJD(sCJD) cases,2 possible sCJD cases and 1 genetic CJD(gCJD) case.In 11 cases,rapidly progressive dementia was the major initial symptom,following by mental symptoms,extrapyramidal symptoms,signs and cerebellum cortical blindness.Clinical symptoms of progressive dementia were the main symptoms,following by visual or cerebellar dysfunction,myoclonus,cone system/extrapyramidal dysfunction,and akinetic mutism.Most of cases were abnormal in MRI (45.45%) and 14-3-3 protein detection in CSF(70%).The 14-3-3 blood samples of prion gene 129 amino acids (PRNP)polymorphisms were M/M type,excepting for 1 case gCJD confirmed diagnosis cases with D178N mutation in PRNP gene.Eleven CJD cases did not show season and regional clusterings and vocational tendency.The majority of the cases were male,the median age was 65,and mainly were the Han nationality.For all cases of CJD reported during that year for follow-up,the lost-tofollow-up rate was 27%,and the majority of cases died within one year.The sCJD cases were the majority in CJD cases of Guizhou Province,2010-2015.The epidemiological characteristics were similar to the national monitoring cases in the same period.
5.The epitope study on the SARS-CoV nucleocapsid protein.
Shuting LI ; Liang LIN ; Hao WANG ; Jianning YIN ; Yan REN ; Zhe ZHAO ; Jie WEN ; Cuiqi ZHOU ; Xumin ZHANG ; Xiaolei LI ; Jingqiang WANG ; Zhengfeng ZHOU ; Jinxiu LIU ; Jianmin SHAO ; Tingting LEI ; Jianqiu FANG ; Ningzhi XU ; Siqi LIU
Genomics, Proteomics & Bioinformatics 2003;1(3):198-206
The nucleocapsid protein (N protein) has been found to be an antigenic protein in a number of coronaviruses. Whether the N protein in severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is antigenic remains to be elucidated. Using Western blot and Enzyme-linked Immunosorbent Assay (ELISA), the recombinant N proteins and the synthesized peptides derived from the N protein were screened in sera from SARS patients. All patient sera in this study displayed strong positive immunoreactivities against the recombinant N proteins, whereas normal sera gave negative immunoresponses to these proteins, indicating that the N protein of SARS-CoV is an antigenic protein. Furthermore, the epitope sites in the N protein were determined by competition experiments, in which the recombinant proteins or the synthesized peptides competed against the SARS-CoV proteins to bind to the antibodies raised in SARS sera. One epitope site located at the C-terminus was confirmed as the most antigenic region in this protein. A detailed screening of peptide with ELISA demonstrated that the amino sequence from Codons 371 to 407 was the epitope site at the C-terminus of the N protein. Understanding of the epitope sites could be very significant for developing an effective diagnostic approach to SARS.
Blotting, Western
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes
;
chemistry
;
immunology
;
Humans
;
Nucleocapsid Proteins
;
chemistry
;
immunology
;
Peptide Fragments
;
chemical synthesis
;
Plasmids
;
Recombinant Proteins
;
immunology
;
isolation & purification
;
metabolism
;
SARS Virus
;
genetics
;
immunology
;
metabolism
6.Mass spectrometry analysis of intact protein N-glycosylation signatures of cells and sera in pancreatic adenocarcinomas.
Mingming XU ; Zhaoliang LIU ; Wenhua HU ; Ying HAN ; Zhen WU ; Sufeng CHEN ; Peng XIA ; Jing DU ; Xumin ZHANG ; Piliang HAO ; Jun XIA ; Shuang YANG
Journal of Zhejiang University. Science. B 2024;25(1):51-64
Pancreatic cancer is among the most malignant cancers, and thus early intervention is the key to better survival outcomes. However, no methods have been derived that can reliably identify early precursors of development into malignancy. Therefore, it is urgent to discover early molecular changes during pancreatic tumorigenesis. As aberrant glycosylation is closely associated with cancer progression, numerous efforts have been made to mine glycosylation changes as biomarkers for diagnosis; however, detailed glycoproteomic information, especially site-specific N-glycosylation changes in pancreatic cancer with and without drug treatment, needs to be further explored. Herein, we used comprehensive solid-phase chemoenzymatic glycoproteomics to analyze glycans, glycosites, and intact glycopeptides in pancreatic cancer cells and patient sera. The profiling of N-glycans in cancer cells revealed an increase in the secreted glycoproteins from the primary tumor of MIA PaCa-2 cells, whereas human sera, which contain many secreted glycoproteins, had significant changes of glycans at their specific glycosites. These results indicated the potential role for tumor-specific glycosylation as disease biomarkers. We also found that AMG-510, a small molecule inhibitor against Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation, profoundly reduced the glycosylation level in MIA PaCa-2 cells, suggesting that KRAS plays a role in the cellular glycosylation process, and thus glycosylation inhibition contributes to the anti-tumor effect of AMG-510.
Humans
;
Glycosylation
;
Pancreatic Neoplasms/pathology*
;
Adenocarcinoma
;
Proto-Oncogene Proteins p21(ras)/metabolism*
;
Glycoproteins
;
Mass Spectrometry
;
Biomarkers/metabolism*
;
Polysaccharides